Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

Clinical trial NCT07101471 · COMPLETED

Trial details

NCT number: NCT07101471
Sponsor: NanoAlvand
Status: COMPLETED
Study type: OBSERVATIONAL

Alopecia Totalis/Universalis Alopecia Areata(AA)

Start date: 2020-08-04
Primary completion: 2025-06-11
Enrollment: 296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.